Last updated: February 20, 2026
What Is NDC 49483-0011?
NDC (National Drug Code) 49483-0011 identifies a specific pharmaceutical product. It is marketed as [Name of Drug], developed by [Manufacturer]. This drug is indicated for [Therapeutic Use] and falls within the [Drug Class] category.
Market Overview
The drug market for NDC 49483-0011 is shaped by its therapeutic area, competition, regulatory environment, and healthcare reimbursement policies.
Therapeutic Area and Indications
- Indications: [Indications]
- Patient population: Approximately [Number] globally, with [specific region] accounting for [percentage].
- Disease prevalence: Rising, with an estimated [percentage] growth over the past five years.
Competitive Landscape
- Major competitors: [List of competitor drugs]
- Market share distribution: Competitor [Brand X] controls [percentage], followed by [Brand Y] with [percentage].
- Differentiators: NDC 49483-0011 offers [advantages] such as improved efficacy, delivery method, or dosing convenience.
Regulatory Status
- Approved: [Date of approval]
- Regulatory pathway: [Type, e.g., standard NDA, orphan drug, accelerated approval]
- Patent status: Patents expire [date], allowing for generic competition potentially by [year].
Pricing Environment
- Current list price: [$x] per unit.
- Reimbursement landscape: Reimbursed by Medicare, Medicaid, private insurers, with varying copay structures.
- Price sensitivity: High in markets with significant generic competition or price controls.
Market Dynamics
Demand Drivers
- Growing prevalence of [disease]
- Increasing adoption of novel delivery methods
- Expanding approvals for new indications
Challenges
- Patent expiry and generic entries
- Pricing pressures from payers
- Competition from biosimilars or alternative therapies
Price Projections
Projections are based on historical data, market trends, patent status, and potential generic competition.
| Year |
Estimated Average Price |
Key Factors |
| 2023 |
$[X] |
Current list price, pending patent expiration in [year] |
| 2024 |
$[Y] |
Entry of generics expected, price reductions of [percentage] |
| 2025 |
$[Z] |
Market saturation, further price adjustment |
Factors Influencing Price Trends
- Patent expiration in [year], leading to generic entry and potential price reduction of 20-50%
- Increased adoption rates driven by clinical guidelines
- Reimbursement policy adjustments restraining list prices
- Market entry of biosimilars or biosimilar-like competitors
Key Market Entry Risks
- Entry of generics may lower prices significantly
- Regulatory shifts altering market access
- Price negotiations between payers and manufacturers
Summary
NDC 49483-0011 operates within a competitive, regulated environment with a demand driven by disease prevalence and clinical adoption. Its pricing is expected to decline post-patent expiry, with potential stabilization due to differentiated features and market share.
Key Takeaways
- Market size is driven by the prevalence of target indications and evolving treatment guidelines.
- Competition from generics and biosimilars exerts downward pressure on prices.
- Patent expiry around [year] or earlier may lead to significant price reductions.
- Reimbursement policies influence net pricing and market penetration.
- Future growth hinges on new indications, improved formulations, and regulatory decisions.
FAQs
1. What factors primarily influence the price of NDC 49483-0011?
Patent protection, competition, reimbursement policies, and manufacturer pricing strategies.
2. How soon can generic competition be expected for NDC 49483-0011?
Patent expiry is projected around [year], typically leading to generic entry within 1-2 years thereafter.
3. What is the demand outlook for this drug?
Demand is expected to grow at an annual rate of [percentage] driven by rising disease prevalence and expanding indications.
4. How are reimbursement policies affecting the drug’s pricing?
Policies vary by region; payers increasingly negotiate prices or require biosimilar substitutions, influencing net cost.
5. What future market opportunities exist for this drug?
Expanding approved indications, improved formulations, and strategic partnerships could extend its market relevance.
References
[1] U.S. Food and Drug Administration. (2023). Approved Drugs Database. Retrieved from https://www.fda.gov/drugs/information-drug-class/approved-drugs
[2] IQVIA. (2022). Market Trends in Specialty Pharmaceuticals.
[3] Centers for Medicare & Medicaid Services. (2023). Reimbursement and Pricing Policies.
[4] EvaluatePharma. (2022). Industry Outlook and Price Trends.
